Early research (Phase 1)Ended earlyNCT03656627
What this trial is testing
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Who this might be right for
Autoimmune DiseasesNon-small Cell Lung CancerRheumatoid Arthritis+7 more
Alliance Foundation Trials, LLC. 7